[{"address1": "Paasheuvelweg 25", "city": "Amsterdam", "zip": "1105 BP", "country": "Netherlands", "phone": "31 20 240 6000", "website": "https://www.uniqure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.", "fullTimeEmployees": 209, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew Craig Kapusta CPA", "age": 52, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 1017357, "exercisedValue": 0, "unexercisedValue": 96250}, {"maxAge": 1, "name": "Mr. Christian  Klemt", "age": 51, "title": "CFO, Principal Financial Officer & GM of Amsterdam Site", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 575462, "exercisedValue": 0, "unexercisedValue": 21000}, {"maxAge": 1, "name": "Mr. Richard  Porter Ph.D.", "age": 55, "title": "Chief Business & Scientific Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 732169, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeannette  Potts J.D., Ph.D.", "age": 62, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 635561, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Hugo  Katus", "title": "Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Amin  Abujoub Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamara  Tugal Ph.D., MBA", "title": "Business Development Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Boyer", "title": "Chief People & Culture Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Walid  Abi-Saab M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Eileen  Sawyer", "title": "Vice President of Global Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.78, "open": 14.0, "dayLow": 13.86, "dayHigh": 14.68, "regularMarketPreviousClose": 13.78, "regularMarketOpen": 14.0, "regularMarketDayLow": 13.86, "regularMarketDayHigh": 14.68, "payoutRatio": 0.0, "beta": 0.363, "forwardPE": -4.640523, "volume": 1017054, "regularMarketVolume": 1017054, "averageVolume": 1114973, "averageVolume10days": 1014000, "averageDailyVolume10Day": 1014000, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 767891968, "fiftyTwoWeekLow": 3.73, "fiftyTwoWeekHigh": 19.18, "priceToSalesTrailing12Months": 28.315645, "fiftyDayAverage": 14.2112, "twoHundredDayAverage": 8.8738, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 901361664, "profitMargins": 0.0, "floatShares": 44295995, "sharesOutstanding": 54076900, "sharesShort": 2567096, "sharesShortPriorMonth": 3196574, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0475, "heldPercentInsiders": 0.085930005, "heldPercentInstitutions": 0.77636003, "shortRatio": 2.88, "shortPercentOfFloat": 0.0479, "impliedSharesOutstanding": 54076900, "bookValue": -0.138, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -239556000, "trailingEps": -4.92, "forwardEps": -3.06, "enterpriseToRevenue": 33.237, "enterpriseToEbitda": -5.32, "52WeekChange": 1.8571429, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 14.2, "targetHighPrice": 72.566925, "targetLowPrice": 18.822634, "targetMeanPrice": 36.19271, "targetMedianPrice": 30.325354, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 367520992, "totalCashPerShare": 6.796, "ebitda": -169430000, "totalDebt": 500991008, "quickRatio": 9.323, "currentRatio": 9.744, "totalRevenue": 27119000, "revenuePerShare": 0.557, "returnOnAssets": -0.16394, "returnOnEquity": -2.38461, "grossProfits": -132840000, "freeCashflow": -139787504, "operatingCashflow": -182728000, "revenueGrowth": -0.219, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -7.9626503, "financialCurrency": "USD", "symbol": "QURE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "messageBoardId": "finmb_171029664", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "uniQure N.V.", "longName": "uniQure N.V.", "corporateActions": [], "postMarketTime": 1741996525, "regularMarketTime": 1741982400, "exchange": "NMS", "earningsTimestamp": 1740657900, "earningsTimestampStart": 1740657900, "earningsTimestampEnd": 1740657900, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.92, "epsForward": -3.06, "epsCurrentYear": -3.63733, "priceEpsCurrentYear": -3.9039624, "fiftyDayAverageChange": -0.011199951, "fiftyDayAverageChangePercent": -0.00078810734, "twoHundredDayAverageChange": 5.3261995, "twoHundredDayAverageChangePercent": 0.60021627, "priceToBook": -102.89855, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1391610600000, "postMarketChangePercent": 3.30986, "postMarketPrice": 14.67, "postMarketChange": 0.47, "regularMarketChange": 0.42000008, "regularMarketDayRange": "13.86 - 14.68", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1114973, "fiftyTwoWeekLowChange": 10.469999, "fiftyTwoWeekLowChangePercent": 2.8069704, "fiftyTwoWeekRange": "3.73 - 19.18", "fiftyTwoWeekHighChange": -4.9800005, "fiftyTwoWeekHighChangePercent": -0.2596455, "fiftyTwoWeekChangePercent": 185.7143, "regularMarketChangePercent": 3.0478961, "regularMarketPrice": 14.2, "marketState": "CLOSED", "displayName": "uniQure", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]